Duncker Streett & Co’s Novavax NVAX Stock Holding History

Duncker Streett & Co’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$40K	Hold	4,242	–	–	0.01%	343
2026 Q1	$34.5K	Buy	4,242 +3,825	+917%	+$34.7K	0.01%	355
2025 Q4	$2.8K	Hold	417	–	–	﹤0.01%	475
2025 Q3	$3.62K	Hold	417	–	–	﹤0.01%	475
2025 Q2	$2.63K	Hold	417	–	–	﹤0.01%	469
2025 Q1	$2.67K	Hold	417	–	–	﹤0.01%	463
2024 Q4	$3.35K	Hold	417	–	–	﹤0.01%	484
2024 Q3	$5.27K	Hold	417	–	–	﹤0.01%	431
2024 Q2	$5.28K	Hold	417	–	–	﹤0.01%	435
2024 Q1	$1.99K	Hold	417	–	–	﹤0.01%	446
2023 Q4	$2K	Hold	417	–	–	﹤0.01%	453
2023 Q3	$3.02K	Hold	417	–	–	﹤0.01%	446
2023 Q2	$3.1K	Hold	417	–	–	﹤0.01%	450
2023 Q1	$2.89K	Hold	417	–	–	﹤0.01%	436
2022 Q4	$4.29K	Hold	417	–	–	﹤0.01%	448
2022 Q3	$8K	Hold	417	–	–	﹤0.01%	405
2022 Q2	$21K	Hold	417	–	–	0.01%	362
2022 Q1	$31K	Hold	417	–	–	0.01%	347
2021 Q4	$60K	Hold	417	–	–	0.01%	325
2021 Q3	$86K	Hold	417	–	–	0.02%	301
2021 Q2	$89K	Hold	417	–	–	0.02%	295
2021 Q1	$76K	Buy	417 +180	+76%	+$35.9K	0.01%	306
2020 Q4	$26K	Hold	237	–	–	0.01%	384
2020 Q3	$26K	Buy	+237	New	+$28.9K	0.01%	368
2019 Q1	–	Sell	-50	Closed	-$2K	–	574
2018 Q4	$2K	Hold	50	–	–	﹤0.01%	545
2018 Q3	$2K	Hold	50	–	–	﹤0.01%	565
2018 Q2	$1K	Hold	50	–	–	﹤0.01%	582
2018 Q1	$2K	Buy	+50	New	+$2.01K	﹤0.01%	576

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Duncker Streett & Co's NVAX Position: Q2 2026 in Review

Duncker Streett & Co held its Novavax (NVAX) position steady in Q2 2026 at 4,242 shares worth $40K. The position accounts for 0.01% of the portfolio, ranked #343.

Duncker Streett & Co first reported a position in NVAX in Q1 2018 and has held it in 28 quarters since. The position peaked at $89K in Q2 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

Duncker Streett & Co held 4,242 shares of Novavax worth $40K as of Q2 2026.
Duncker Streett & Co left its Novavax share count unchanged in Q2 2026.
Novavax made up 0.01% of Duncker Streett & Co's portfolio in Q2 2026, its #343 holding.
Duncker Streett & Co first reported a position in Novavax in Q1 2018 and has held it in 28 quarters since.
Duncker Streett & Co's Novavax position peaked at $89K in Q2 2021.
266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Duncker Streett & Co's 13F filing for Q2 2026, filed 28 Jul 2026.